From: Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitors
Target kinase
Total test set compounds
Active inhibitors
Inactive decoys
VEGFR-2
827
26
801
FGFR-1
620
20
600
BRAF
940
27
913
Total
2387
73
2314